Navigation Links
Research is getting closer to understanding critical nucleus in haze formation, prof says
Date:6/16/2010

COLLEGE STATION, June 14, 2010 - Haze, scientifically known as atmospheric aerosols - microscopic particles suspended in the Earth's atmosphere - represents a major environmental problem because it degrades visibility, affects human health and influences the climate. Despite its profound impacts, how the haze is formed is not fully understood, says a Texas A&M University professor of atmospheric sciences and chemistry who has studied air chemistry for more than 20 years.

Professor Renyi Zhang published his work in the June 11 issue of Science magazine, summarizing recent findings and new research directions that could pave the way for a better understanding of aerosol formation.

"Aerosols, also referred to as haze, influence climate by absorbing and reflecting solar radiation and modifying cloud formation," he explains. "A better understanding of how aerosols form in the atmosphere will greatly improve climate models.

"But, formation of aerosols in the atmosphere is not fully understood, particularly at the molecular level, creating one of the largest sources of uncertainty in climate predictions," he adds.

For aerosols to form, the bonding particles must cross an energy threshold, which the scientists call nucleation barrier. Once the barrier is crossed, aerosol formation can happen spontaneously, he notes.

The interaction between organic acids and sulfuric acid can facilitate the crossing of the barrier by creating a critical nucleus, the Texas A&M professor says in the Science article.

Large amounts of organic gases are emitted to the atmosphere by plants, industry and automobiles and form organic acids; sulfur dioxide, on the other hand, are produced by human activities, such as burning coals, and then form sulfuric acid.

To better understand aerosol formation, scientists need to predict the nucleation rate based on knowledge of the composition of the critical nucleus, Zhang explains.


'/>"/>
Contact: Keith Randall
keith-randall@tamu.edu
979-845-4644
Texas A&M University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Research shows skeleton to be endocrine organ
2. Newly created cancer stem cells could aid breast cancer research
3. Dominant cholesterol-metabolism ideas challenged by new research
4. Researchers identify proteins involved in new neurodegenerative syndrome
5. Texas researchers and educators head for Antarctica
6. MGH researchers describe new way to identify, evolve novel enzymes
7. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
8. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
9. U of MN researchers discover noninvasive diagnostic tool for brain diseases
10. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
11. Story ideas from the Journal of Lipid Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014) Scientists at The New York Stem ... closer to creating a viable cell replacement therapy ... , For the first time, NYSCF scientists ... skin samples of patients with primary progressive multiple ... to induce these stem cells into becoming oligodendrocytes, ...
(Date:7/24/2014)... 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced ... control Phase 3 study of Zerenex (ferric citrate), the ... treatment of hyperphosphatemia in patients with end-stage renal disease ... iRon delivery with FErric CiTrate in EsrD) was published ... Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... YORK, NY (July 24, 2014) Scientists at ... Institute are one step closer to creating a ... a patient,s own cells. , For the ... (iPS) cells lines from skin samples of patients ... developed an accelerated protocol to induce these stem ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
... directed by Scripps Research Professor Benjamin Cravatt, Ph.D., ... of The Journal of Biological Chemistry. , The ... previously suggested-for the biosynthesis of neurotransmitter lipids, N-acyl ... anandamide. The high activity of the enzyme a/b ...
... within the cell nucleus and performs one of the ... machines that convert the genetic information carried by messenger ... , Gary Karpen and Jamy Peng, researchers in ... Lawrence Berkeley National Laboratory, have now discovered two pathways ...
... Scripps Research Professor Benjamin Cravatt, Ph.D., is being ... Journal of Biological Chemistry. , The new study ... the biosynthesis of neurotransmitter lipids, N-acyl ethanolamines (NAEs), ... high activity of the enzyme a/b hydrolase4 (Abh4) ...
Cached Biology News:Nanotechnology propels advances in regenerative medicine research 2Regulating the nuclear architecture of the cell 2Regulating the nuclear architecture of the cell 3Regulating the nuclear architecture of the cell 4Regulating the nuclear architecture of the cell 5Brown seaweed contains promising fat fighter, weight reducer 2
(Date:7/24/2014)... Draper University, a top program ... announce that for 6 weeks this summer, 39 ... on the Draper University campus in the heart ... focused on entrepreneurship, building real-world skills, and “learning ... its sixth cohort, continues to refresh its curriculum ...
(Date:7/24/2014)... 24, 2014   Cypher Genomics, Inc., ... of Adam Simpson as president and ... and comprehensive annotation and interpretation of individual human ... "Cypher,s technology has the potential to play ... diagnostic accuracy, optimizing therapeutic approaches and reducing adverse ...
(Date:7/24/2014)... San Diego, CA (PRWEB) July 24, 2014 ... in the reporting of molecular diagnostic test results. ... tracking capabilities necessary for the validation and reporting ... in oncology. Molecular diagnostics is a rapidly growing ... for infectious disease, genetic predisposition, cancer, and companion ...
(Date:7/23/2014)... United Arab Emirates (UAE) (PRWEB) July 23, 2014 ... Grace Century recently announced that its biobanking project, ... Vaught , Ph.D. to its growing Advisory Board. ... are very pleased to have Dr. Vaught onboard with ... scientific depth and expertise that Provia’s management team brings ...
Breaking Biology Technology:Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 3New DNA-barcode Patent Virtually Eliminates False Test Results and Sample Mix-up 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 3Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 4
... (TCI), a Los,Angeles-based DNA and genomics research and ... office in the heart of Boston,s legal and,financial ... of,chemical and toxic exposures on human health and ... Consulting, TCI now offers a,range of business, financial, ...
... Watson,Pharmaceuticals, Inc. (NYSE: WPI ), a leading ... will provide an,overview of the Company,s business at ... September 10, 2007 at 3:30 p.m. Eastern,Daylight Time. ... can be accessed on Watson,Pharmaceuticals, Investor Relations Web ...
... INDIANAPOLIS and SOUTH SAN FRANCISCO, Calif., Sept. 4, ... Dow Chemical Company (NYSE: DOW ), and ... Inc. (Nasdaq: EXEL ), announced today,that the ... includes the purchase of selected assets by Dow ...
Cached Biology Technology:Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases 2Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation 2Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation 3
... ZMD.473. Immunogen: Synthetic peptide derived ... mouse junctophilin-2. Specificity: Specific for ... (positive controls: mouse skeletal muscle homogenates ... Applications: Western blotting Immunohistochemistry(froz) ImmunofluorescenceStorage: Store ...
Laminin gamma-2 (G-16)...
ABIN-2 Polyclonal Ab 100 ug rabbit polyclonal antibody. Detects ABIN-2 in human/mouse. Tested in WB....
Syd-2 (cL-19)...
Biology Products: